Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» age-related macular degeneration
age-related macular degeneration
Italy's move to fund unapproved use of Roche's Avastin alarms the industry
Fierce Pharma
Wed, 06/11/14 - 10:47 am
Italy
Roche
Avastin
age-related macular degeneration
Using Avastin for Eye Disorder Could Save U.S. $3 Billion
Bloomberg
Mon, 06/2/14 - 06:13 pm
Avastin
Roche
Lucentis
age-related macular degeneration
diabetic macular edema
StemCells advances HuCNS-SC clinical trial to final cohort
The Fly on the Wall
Thu, 05/22/14 - 08:39 am
StemCells
HuCNS-SC
clinical trials
age-related macular degeneration
BioTime Joins Advanced Cell Technology In The AMD Race
Seeking Alpha
Mon, 03/24/14 - 10:41 am
BioTime
Advanced Cell Technology
age-related macular degeneration
Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases - Angel Broking
Equity Bulls
Sat, 10/5/13 - 10:26 am
Sun Pharma
Intrexon
wet age-related macular degeneration
age-related macular degeneration
macular
edema
uveitis
diabetic retinopathy
Regeneron Shareholders Watching Optina Trial Closely
Seeking Alpha
Thu, 05/23/13 - 11:32 am
Optina
Regeneron
Novartis
Eylea
Ampio Pharmaceuticals
age-related macular degeneration
Lucentis
Regeneron Pharma raises sales forecast for Eylea
Yahoo/AP
Sat, 05/4/13 - 10:26 am
Regeneron
Eylea
age-related macular degeneration
macular degeneration
Regeneron's Flagship Drug Treats Blindness In Seniors
Investors.com
Fri, 04/12/13 - 09:56 am
Regeneron
age-related macular degeneration
Eylea
Age-Related Macular Degeneration: A Promising Investment Opportunity
Seeking Alpha
Tue, 01/22/13 - 10:43 am
age-related macular degeneration
Lpath
Merck
Pfizer
Bristol-Myers Squibb
Roche
ShangPharma
2 Drug Approvals and Shares Drop? That's Biotech!
Motley Fool
Tue, 09/25/12 - 09:46 am
Regeneron
Eylea
macular edema
age-related macular degeneration
Valeant buys Visudyne drug from QLT; QLT stock jumps
Reuters
Mon, 09/24/12 - 11:20 am
Valeant Pharmaceuticals
Visudyne
QLT
age-related macular degeneration
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
Yahoo/PR NewsWire
Sat, 11/19/11 - 11:36 am
Regeneron
Eylea
macular degeneration
age-related macular degeneration
VA Reinstates Avastin Usage For Eye Disease
Pharmalot
Thu, 11/10/11 - 01:13 pm
Veterans Administration
Avastin
Lucentis
age-related macular degeneration
Genentech
Regeneron Soars on Eye-Drug Rival Setback
TheStreet.com
Wed, 09/21/11 - 11:24 pm
Regeneron
Roche
Avastin
wet-AMD
age-related macular degeneration
Regeneron Pharmaceuticals Shares Plunged: What You Need to Know
Motley Fool
Sat, 09/10/11 - 09:55 am
Regeneron
Eylea
age-related macular degeneration
Off-Label Avastin Use, Medicare And Saving Money
Pharmalot
Wed, 09/7/11 - 09:54 am
Medicare
off-label
Avastin
Roche
Genentech
age-related macular degeneration
pSivida on the Cusp of Big Breakthrough
Seeking Alpha
Tue, 07/5/11 - 04:39 pm
Pfizer
pSivida
diabetic macular edema
injectables
age-related macular degeneration
Durasert
glaucoma
Bayer Seeks European Approval
Yahoo/Zacks
Sat, 06/11/11 - 10:27 am
Bayer
VEGF Trap-Eye
age-related macular degeneration
Novartis girds for rival Regeneron eye drug
Reuters
Fri, 05/13/11 - 10:42 am
Regeneron
Novartis
Lucentis
VEGF Trap-Eye
age-related macular degeneration
Roche Holding’s Avastin Treatment Effective for Blindness in Study
Bloomberg
Sat, 04/30/11 - 09:51 am
Roche
Avastin
age-related macular degeneration
Pages
« first
‹ previous
1
2
3
next ›
last »